Rational selection of biomarker driven therapies for gynecologic cancers: The more we know, the more we know we don’t know

Por Liu, Joyce, Westin, Shannon N.
Publicado no Gynecol Oncol (2016)

The European Society of Gynecologic Oncology (ESGO) 19(th) Biannual Meeting: Overview and summary of selected topics

Por Westin, Shannon N., Randall, Leslie
Publicado no Gynecol Oncol (2016)

Personalized therapy in endometrial cancer: Challenges and opportunities

Por Westin, Shannon N, Broaddus, Russell R
Publicado em 2012

Individualized Medicine in Ovarian Cancer: Are We There Yet?

Por Westin, Shannon N., Coleman, Robert L.
Publicado no Gynecol Oncol (2017)

Application of Immunohistochemistry and Molecular Diagnostics to Clinically Relevant Problems in Endometrial Cancer Bojana Djordjevic, Shannon Westin, Russell R. Broaddus

Por Djordjevic, Bojana, Westin, Shannon, Broaddus, Russell R.
Publicado em 2012

Status epilepticus associated with platinum chemotherapy in a patient with cervical cancer: a case report

Por Holman, Laura L., Ren, Yulan, Westin, Shannon N.
Publicado no BMC Cancer (2015)

Pushing the envelope: expanding fertility sparing treatment of endometrial cancer

Por Stewart, Katherine Ikard, Yates, Melinda S., Westin, Shannon N.
Publicado no J Gynecol Oncol (2020)

Movement of Poly-ADP Ribose (PARP) Inhibition Into Frontline Treatment of Ovarian Cancer

Por Onstad, Michaela, Coleman, Robert L., Westin, Shannon N.
Publicado no Drugs (2020)

Current and future landscape of PARPi resistance

Por Hinchcliff, Emily, Chelariu-Raicu, Anca, Westin, Shannon N.
Publicado no Curr Opin Obstet Gynecol (2021)

Repurposing the Pap Smear: One Step Closer to Gynecologic Cancer Screening

Por Westin, Shannon N., Mills, Gordon B., Myers, Andrea P.
Publicado em 2013

Investigational Agents in Development for the Treatment of Ovarian Cancer

Por Westin, Shannon N., Herzog, Thomas J., Coleman, Robert L.
Publicado em 2012

MICROSATELLITE INSTABILITY IN ENDOMETRIAL CANCER: NEW PURPOSE FOR AN OLD TEST

Por Kurnit, Katherine C., Westin, Shannon N., Coleman, Robert L.
Publicado no Cancer (2019)

Rapidly Changing Landscape of Fallopian Tube Carcinoma

Por Kurnit, Katherine C., Lu, Karen H., Westin, Shannon N.
Publicado no J Oncol Pract (2019)

Early Cervical Neoplasia: Advances in Screening and Treatment Modalities

Por Tierney, Brent, Westin, Shannon N., Schlumbrecht, Matthew P., Ramirez, Pedro T.
Publicado no Clin Adv Hematol Oncol (2010)

Unusual indolent behavior of leiomyosarcoma of the vagina: Is observation a viable option?

Por Khafagy, Ayatallah M., Prescott, Lauren S., Malpica, Anais, Westin, Shannon N.
Publicado no Gynecol Oncol Rep (2017)

Rucaparib in ovarian cancer: extending the use of PARP inhibitors in the recurrent disease

Por Dal Molin, Graziela Z, Westin, Shannon N, Coleman, Robert L
Publicado no Future Oncol (2018)

Progestin Intrauterine Device in an Adolescent With Grade 2 Endometrial Cancer

Por Brown, Alaina J., Westin, Shannon N., Broaddus, Russell R., Schmeler, Kathleen
Publicado em 2012

A non-pregnant woman with elevated beta-HCG: A case of para-neoplastic syndrome in ovarian cancer

Por Goldstein, Jennifer, Pandey, Prasamsa, Fleming, Nicole, Westin, Shannon, Piha-Paul, Sarina
Publicado no Gynecol Oncol Rep (2016)

Phase I study of the PARP inhibitor talazoparib with radiation therapy for locally recurrent gynecologic cancers

Por Lakomy, David S., Urbauer, Diana L., Westin, Shannon N., Lin, Lilie L.
Publicado no Clin Transl Radiat Oncol (2019)

Clinical Investigation of Receptor and Non-Receptor Tyrosine Kinase Inhibitors for the Treatment of Epithelial Ovarian Cancer

Por Klempner, Samuel J., Myers, Andrea P., Mills, Gordon B., Westin, Shannon N.
Publicado em 2013